Microarray market research reports by Nova One Advisor

U.S. Oncology Molecular Diagnostics Market (By Type: Breast Cancer, Liver Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Other Cancer, By Technology; PCR, Sequencing, In Situ Hybridization, INAAT, Chips and Microarrays, Mass Spectrometry, TMA, Others; By Product, Reagents, Instruments, Others)) - Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033

May 26, 2025  |  Published by: Nova One Advisor  |  USD 3,800

The U.S. oncology molecular diagnostics market size was estimated at USD 0.85 billion in 2023 and is projected to hit around USD 2.74 billion by 2033, growing at a CAGR of 12.41% during the forecast period from 2024 to 2033. U.S. Oncology Molecular Diagnostics Market Key Takeaways By type, the breas ... Read More